Skip to main content

1 Size Doesn’t Fit All: PBPK M&S for Individual Risk of Complex DDIs

Drug-drug interactions (DDIs) are a primary threat to the safety and efficacy of clinical practice. Clinically relevant drug interactions are primarily due to drug-induced alterations in the activity and quantity of metabolic enzymes and transporters. Indeed, DDIs that cause unmanageable, severe adverse effects have led to restrictions in clinical use and even, drug withdrawals from … Continued

1 of 1
Powered by GlobalLink OneLink Software